Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial

Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden message rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T13:20:56.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T13:56:27.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T13:54:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:47:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content with an access-restricted message. This indicates the page is currently blocked or unavailable to the public.
    Difference
    18%
    Check dated 2026-09-19T22:05:36.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now displayed, replacing the previous v3.6.5, indicating a minor maintenance update to the page's underlying version.
    Difference
    0.1%
    Check dated 2026-08-29T20:07:59.000Z thumbnail image

Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.